Abstract
Cefmenoxime, an investigational semisynthetic cephalosporin, was evaluated in 18 pediatric patients with a variety of infections. There were seven patients with urinary tract infections, two with wound infections, two with osteomyelitis, two with abscess infections, one with cervical adenitis, one with hidradenitis, one with pneumonia and sepsis, one with periorbital cellulitis, and one with ventriculitis. A total of 16 (88%) patients had a satisfactory clinical response demonstrated by improvement in clinical signs and symptoms. A total of 12 (67%) patients demonstrated eradication of their infecting organisms. Of the pathogens isolated in these patients, 16 isolates were susceptible to cefmenoxime. One patient developed a generalized urticarial rash that resolved within 24 h after cessation of cefmenoxime therapy. Mean peak level in serum after intravenous infusion was 55 micrograms/ml.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahonkhai V. I., Cherubin C. E., Shulman M. A., Bancroft U. Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility. Antimicrob Agents Chemother. 1982 Jun;21(6):999–1002. doi: 10.1128/aac.21.6.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gombert M. E., Glasser L. A., Eng R. H. Cefmenoxime therapy of serious bacterial infections. Antimicrob Agents Chemother. 1984 Apr;25(4):510–512. doi: 10.1128/aac.25.4.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Granneman G. R., Sennello L. T., Steinberg F. J., Sonders R. C. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects. Antimicrob Agents Chemother. 1982 Jan;21(1):141–145. doi: 10.1128/aac.21.1.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LeFrock J. L., Molavi A., McCloskey R. V., Rolston K., Chandrasekar P., Henao L., Smith B. R., Kannangara W., Schell R. F., Carr B. B. Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies. Am J Med. 1984 Jul;77(1):72–78. doi: 10.1016/0002-9343(84)90438-8. [DOI] [PubMed] [Google Scholar]
- Schell R. F., Smith B. R., LeFrock J. L., Francisco M. A. Antimicrobial activity of cefmenoxime compared with those of other cephalosporins. Antimicrob Agents Chemother. 1983 May;23(5):774–777. doi: 10.1128/aac.23.5.774. [DOI] [PMC free article] [PubMed] [Google Scholar]